| scholarly article | Q13442814 |
| P50 | author | Axel Finckh | Q37830959 |
| P2093 | author name string | Martin R Tramèr | |
| P2860 | cites work | The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey | Q24282603 |
| The case of the misleading funnel plot | Q24676535 | ||
| Impact of covert duplicate publication on meta-analysis: a case study | Q24685600 | ||
| More insight into the fate of biomedical meeting abstracts: a systematic review | Q24795030 | ||
| Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses | Q27860840 | ||
| Citation bias of hepato-biliary randomized clinical trials | Q28212007 | ||
| Study of information submitted by drug companies to licensing authorities | Q28282248 | ||
| Improving the quality of reporting of randomized controlled trials. The CONSORT statement | Q29619101 | ||
| Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses | Q29619185 | ||
| Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials | Q33243658 | ||
| Clinical guidelines: developing guidelines | Q33536430 | ||
| Etanercept plus standard therapy for Wegener's granulomatosis | Q33984596 | ||
| The medical review article: state of the science | Q34191468 | ||
| The existence of publication bias and risk factors for its occurrence | Q34373168 | ||
| Discrepancies between Meta-Analyses and Subsequent Large Randomized, Controlled Trials | Q34436046 | ||
| Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists | Q35554865 | ||
| Is there an association between anti-TNF monoclonal antibody therapy in rheumatoid arthritis and risk of malignancy and serious infection? Commentary on the meta-analysis by Bongartz et al | Q35605656 | ||
| Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study | Q35637884 | ||
| Response to commentary by Dixon and Silman on the systematic review and meta-analysis by Bongartz et al. | Q36588441 | ||
| Reporting in randomized clinical trials improved after adoption of the CONSORT statement | Q36732977 | ||
| Uncertainty in heterogeneity estimates in meta-analyses | Q36987539 | ||
| Full publication of results initially presented in abstracts. A meta-analysis | Q40663320 | ||
| Large trials vs meta-analysis of smaller trials: how do their results compare? | Q40923138 | ||
| What's new in the other general journals. | Q45903741 | ||
| Summing up evidence: one answer is not always enough | Q52900179 | ||
| Issues in Comparisons Between Meta-analyses and Large Trials | Q52901853 | ||
| Language bias in randomised controlled trials published in English and German | Q53358085 | ||
| Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis | Q57995927 | ||
| Predictive ability of meta-analyses of randomised controlled trials | Q58467929 | ||
| The effectiveness of anti–tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: A population-based study | Q61280972 | ||
| Risk of Serious Infections and Malignancies With Anti-TNF Antibody Therapy in Rheumatoid Arthritis | Q63628570 | ||
| Effect of the Statistical Significance of Results on the Time to Completion and Publication of Randomized Efficacy Trials | Q74121809 | ||
| Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials | Q74251746 | ||
| Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis | Q79337326 | ||
| Investigation, explanation, and apology for incomplete and erroneous disclosures | Q79337336 | ||
| Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis | Q94502258 | ||
| Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis | Q94502264 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| P304 | page(s) | 146-152 | |
| P577 | publication date | 2008-03-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Nature Clinical Practice Rheumatology | Q15752269 |
| P1476 | title | Primer: strengths and weaknesses of meta-analysis | |
| P478 | volume | 4 |
| Q53436506 | Body checking and body avoidance in eating disorders: Systematic review and meta-analysis |
| Q41348812 | Divergent Structural Responses to Pharmacological Interventions in Orbitofronto-Striato-Thalamic and Premotor Circuits in Obsessive-Compulsive Disorder. |
| Q36060006 | Is the Best Evidence Good Enough: Quality Assessment and Factor Analysis of Meta-Analyses on Depression |
| Q34454354 | Meta-epidemiology |
| Q38078608 | Newer Antifungal Agents for Fungal Infection Prevention During Hematopoietic Cell Transplantation: A Meta-Analysis |
| Q82244768 | Osteoarthritis: Small studies overestimate the benefit of therapies for OA |
| Q35276047 | Systemic hypertension as a risk factor for open-angle glaucoma: a meta-analysis of population-based studies. |
| Q39036019 | Systemic review and meta-analysis of diagnostic imaging technologies |
| Q38952676 | The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses |
| Q35536869 | Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder |
Search more.